[Elevated Ca 19.9 tumor marker without evidence of malignancy]

Area of Science:

• Oncology
• Gynecologic Oncology
• Biomarkers

Background:

• Tumor markers are widely used for monitoring cancer patients.
• Their diagnostic utility in identifying malignancy remains debated.
• Ca 19.9 is a commonly used tumor marker, particularly for gastrointestinal and pancreatic cancers.

Observation:

• A patient underwent laparoscopic bilateral adnexectomy for a benign ovarian cyst.
• Postoperatively, an unexpected elevation in Ca 19.9 levels was observed.
• The ovarian cyst was histopathologically confirmed as benign.

Findings:

• The elevated Ca 19.9 levels were not associated with a malignant neoplasm.
• This suggests non-malignant conditions can lead to significant increases in Ca 19.9.
• The specific cause of the Ca 19.9 elevation in this benign case requires further investigation.

Implications:

• Relying solely on Ca 19.9 for malignancy diagnosis can be misleading.
• Further research is needed to understand the causes of Ca 19.9 elevation in benign gynecologic conditions.
• Clinical interpretation of Ca 19.9 should consider the full patient context, including benign pathologies.